Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
NCT00026429
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class
Conditions
Leukemia
Lymphoma
Interventions
BIOLOGICAL:
denileukin diftitox
Sponsor
Pharmatech Oncology